Candel Therapeutics, Inc.
CADL
$9.79
$0.323.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -220.08% | -109.59% | -5.85% | 78.43% | 189.76% |
| Total Depreciation and Amortization | -39.18% | -33.47% | -20.41% | -2.81% | -2.39% |
| Total Amortization of Deferred Charges | 595.45% | 405.77% | -66.13% | -56.16% | -46.99% |
| Total Other Non-Cash Items | 58.09% | 106.50% | -84.22% | -129.04% | -1,378.43% |
| Change in Net Operating Assets | -95.67% | 383.85% | -57.82% | -84.81% | -8.50% |
| Cash from Operations | -109.34% | -81.77% | -55.73% | -43.45% | -2.11% |
| Capital Expenditure | -22,400.00% | -13,533.33% | -- | -416.67% | 57.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22,400.00% | -13,533.33% | -- | -416.67% | 57.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -69.32% | 0.00% | 0.00% | -49.97% |
| Issuance of Common Stock | 14,791.27% | -100.00% | -- | 348.68% | 52.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,116.84% | -52.24% | -301.01% | 796.86% | -49.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 816.02% | -61.77% | -180.31% | 300.09% | -8.13% |